TriSalus Life Sciences (TLSI) Interest & Investment Income (2021 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Interest & Investment Income of $164000.0 for Q1 2026, up 121.62% year-over-year from $74000.0 in Q1 2025, and down 7.34% quarter-over-quarter from $177000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Interest & Investment Income (2021 - 2026) Analysis & Trends
TriSalus Life Sciences' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $164000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 121.62% year-over-year to $164000.0; the TTM figure through Mar 2026 stood at $645000.0 (up 67.1% YoY), while the FY2025 annual figure was $555000.0, up 37.38% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $164000.0, down from $177000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $314714.0 in Q2 2022, with the low at $35000.0 in Q1 2023.
- The 5-year median for Interest & Investment Income is $105000.0 (2022), against an average of $122347.9.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income soared 11171.99% in 2022, then plunged 88.56% in 2023.
- TriSalus Life Sciences' Interest & Investment Income stood at $105000.0 in 2022, then jumped by 132.38% to $244000.0 in 2023, then sank by 76.64% to $57000.0 in 2024, then jumped by 210.53% to $177000.0 in 2025, then slipped by 7.34% to $164000.0 in 2026.
- Business Quant data shows TLSI's Interest & Investment Income at $164000.0 in Q1 2026, $177000.0 in Q4 2025, and $170000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | - |
| 10 | TriSalus Life Sciences | 307.64 Mn | 261.36 Mn | 9.90 Mn | 457,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 457,000.00 |
| Mar 31, 2026 | 164,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Sep 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 244,000.00 |
| Sep 30, 2023 | 116,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 314,714.00 |
| Mar 31, 2022 | 57,200.00 |
| Dec 31, 2021 | 7,916.00 |
| Sep 30, 2021 | 18,665.00 |